NCT02483195|WithdrawnPhase 4
Study Stopped
PI indicating she was withdrawing her study submission due to lack of funding as of 6/20/2016
Loading search results
Sponsor study identifier
interventional
0
1 country
1
Study Start
August 2016
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The investigators propose to conduct a head-to-head, randomized clinical trial to compare the effectiveness of Minoxidil with Spironolactone and Finasteride in treating postmenopausal females with Androgenetic Alopecia (AGA).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 24, 2015
Actual (reported)June 26, 2015
Actual (reported)August 2016
Date type not reportedThis date has not been verified as actual or estimated.
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The Savin Scale will be used to determine hair growth and/or hair loss between the groups.
This will be based on a photographic scale from D1 to D8. With D1 being minimal disease and D8 being severe alopecia.
Change at 0, 4, 8, and 12 months
The Ludwig Scale will be used to determine hair growth and/or hair loss between the groups.
This scale is based on the hair loss pattern. Ludwig Scale: Left = pattern 1, middle = pattern 2, right = pattern 3
Change at 0, 4, 8, and 12 months
Alopecia improvement assessment will be used to determine hair growth and/or hair loss between the groups.
The value will be one of 7 numbers, ranging from -3 to +3. The values will stand for the following: * 3: markedly worsened alopecia * 2: moderately worsened alopecia * 1: slightly worsened alopecia 0: no change in alopecia * 1: slightly improved alopecia * 2: moderately improved alopecia * 3: markedly improved alopecia
Change at 0, 4, 8, and 12 months
This group will use a mixed combination of 5% Minoxidil and 200mg Spironolactone for 12 months to be used once daily.
This group will use a mixed combination of 5mg Finasteride with placebo topical preparation for 12 months to be used once daily.
This will be a mixed combination of 5% Minoxidil and 200mg Spironolactone to be used once daily.
This will be a mixed combination of 5% Minoxidil and 200mg Spironolactone to be used once daily.
UF Health
Gainesville, Florida, 32610, United States
Christina L. Mitchell, M.D.
University of Florida
0 participants (actual enrollment reported by the registry).
First Submitted
June 24, 2015
First Posted
June 26, 2015
Study Start
August 2016
Date type not reportedThis date has not been verified as actual or estimated.
High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
This will be a mixed combination of 5mg Finasteride with placebo topical preparation to be used once daily.
This will be a mixed combination of 5mg Finasteride with placebo topical preparation to be used once daily.
Contact the study team to confirm eligibility.
Primary Completion
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 2, 2016
Record last verified: 2016-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: